CompletedNot Applicable

Inter-rater Reliability of the Australian Spasticity Assessment Scale (ASAS) in Post-stroke Spasticity

Turkey (Türkiye)85 participantsStarted 2020-10-20

Plain-language summary

The reliability of the Australian Spasticity Assessment Scale (ASAS) has been reported to be not high enough in adult patients with acquired brain damage. The low number of patients and the heterogeneous study population have been reported as important limitations in the reliability study of this measure. Therefore, the reliability of the ASAS needs to be confirmed in stroke patients with spasticity. This study aims to investigate the inter-rater reliability of the ASAS in a study population consisting of a larger and more homogeneous patient population (those with post-stroke spasticity).

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Chronic stroke (\> 6 months) * Fist stroke * Increased tone according to the Modified Ashworth Scale in at least one of the elbow, wrist, and ankle * Stability of spasticity for the last 3 months Exclusion Criteria: * Increased tone due to causes other than stroke (traumatic brain injury, spinal cord injury, multiple sclerosis, motor neuron disease, etc.) * Acute or subacute stroke (≤6 months) * Recurrent stroke attacks * Presence of contracture and/or moderate to severe pain in the joints to be assessed (elbow, wrist, and ankle) * Botulinum toxin injection in the last three months * History of neurolysis for spasticity (alcohol or phenol) * History of surgery for spasticity * Initiation of a new drug for spasticity, or a change in drug dose

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Australian Spasticity Assessment Scale (ASAS)

Timeframe: Through study completion, an average of 2 year

Trial details

NCT IDNCT04613661

SponsorIzmir Katip Celebi University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-17

View on ClinicalTrials.gov More Hemiplegia, Spastic trials